MAPLELANE CAPITAL, LLC - LIGAND PHARMACEUTICALS INC ownership

LIGAND PHARMACEUTICALS INC's ticker is LGND and the CUSIP is 53220K504. A total of 283 filers reported holding LIGAND PHARMACEUTICALS INC in Q3 2019. The put-call ratio across all filers is 6.41 and the average weighting 0.2%.

Quarter-by-quarter ownership
MAPLELANE CAPITAL, LLC ownership history of LIGAND PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2020$26,852,000
+87.8%
270,000
+80.0%
0.34%
+29.4%
Q3 2020$14,298,000
+6.5%
150,000
+25.0%
0.26%
+4.0%
Q2 2020$13,422,000
-19.8%
120,000
-47.8%
0.25%
-67.2%
Q1 2020$16,726,000
-2.8%
230,000
+39.4%
0.77%
+64.8%
Q4 2019$17,209,000
-40.4%
165,000
-43.1%
0.47%
-28.1%
Q3 2019$28,867,000
-39.2%
290,000
-17.1%
0.65%
-53.0%
Q4 2018$47,495,000350,0011.38%
Other shareholders
LIGAND PHARMACEUTICALS INC shareholders Q3 2019
NameSharesValueWeighting ↓
Knott David M Jr 115,000$6,8912.63%
VILLERE ST DENIS J & CO LLC 438,161$26,254,6072.24%
RICE HALL JAMES & ASSOCIATES, LLC 282,961$16,955,0231.08%
Chicago Capital, LLC 360,345$21,591,8841.01%
CARDINAL CAPITAL MANAGEMENT LLC /CT 206,399$12,367,4280.53%
Smith, Graham & Co., Investment Advisors, LP 61,849$3,705,9920.46%
Stephens Investment Management Group LLC 467,564$28,016,4350.46%
Jackson Creek Investment Advisors LLC 13,657$8180.34%
Court Place Advisors, LLC 15,133$906,7690.32%
Ziegler Capital Management, LLC 123,158$7,379,1760.30%
View complete list of LIGAND PHARMACEUTICALS INC shareholders